Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution

Michelle Chan-Seng-Yue^#^{1

2}, Jaeseung C Kim^#^{1

3}, Gavin W Wilson¹, Karen Ng¹, Eugenia Flores Figueroa¹, Grainne M O'Kane^{2

4}, Ashton A Connor⁵, Robert E Denroche², Robert C Grant⁴, Jessica McLeod¹, Julie M Wilson², Gun Ho Jang², Amy Zhang², Sheng-Ben Liang⁶, Ayelet Borgida⁷, Dianne Chadwick⁶, Sangeetha Kalimuthu⁸, Ilinca Lungu⁹, John M S Bartlett⁹, Paul M Krzyzanowski³, Vandana Sandhu¹, Hervé Tiriac^{10

11

12}, Fieke E M Froeling^{10

11

13}, Joanna M Karasinska¹⁴, James T Topham¹⁴, Daniel J Renouf^{14

15}, David F Schaeffer^{14

16}, Steven J M Jones^{17

18}, Marco A Marra^{17

18}, Janessa Laskin¹⁵, Runjan Chetty⁸, Lincoln D Stein^{19

20}, George Zogopoulos^{21

22}, Benjamin Haibe-Kains^{1

2

23

24}, Peter J Campbell^{25

26}, David A Tuveson^{10

11}, Jennifer J Knox^{2

4}, Sandra E Fischer^{8

27}, Steven Gallinger^{28

29

30

31}, Faiyaz Notta^{32

33

34}

Affiliations

¹ Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
² PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
³ Genomics Technology Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
⁴ Wallace McCain Centre for Pancreatic Cancer, Department of Medical Oncology, Princess Margaret Centre University Health Network, University of Toronto, Toronto, Ontario, Canada.
⁵ Hepatobiliary/Pancreatic Surgical Oncology Program, University Health Network, Toronto, Ontario, Canada.
⁶ UHN Program in BioSpecimen Sciences, University Health Network, Toronto, Ontario, Canada.
⁷ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
⁸ Department of Pathology, University Health Network and University of Toronto, Toronto, Ontario, Canada.
⁹ Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
¹⁰ Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
¹¹ Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor, NY, USA.
¹² Department of Surgery, University of California San Diego, NCI-designated Comprehensive Cancer Center, La Jolla, CA, USA.
¹³ Department of Surgery and Cancer, Imperial College London, London, UK.
¹⁴ Pancreas Centre BC, Vancouver, British Columbia, Canada.
¹⁵ Department of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.
¹⁶ Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.
¹⁷ Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
¹⁸ Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
¹⁹ Bioinformatics, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
²⁰ Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
²¹ Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
²² The Goodman Cancer Research Centre of McGill University, Montreal, Quebec, Canada.
²³ Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
²⁴ Department of Computer Science, University of Toronto, Toronto, Ontario, Canada.
²⁵ Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.
²⁶ Department of Haematology, University of Cambridge, Cambridge, UK.
²⁷ Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
²⁸ PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. steven.gallinger@uhn.ca.
²⁹ Hepatobiliary/Pancreatic Surgical Oncology Program, University Health Network, Toronto, Ontario, Canada. steven.gallinger@uhn.ca.
³⁰ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. steven.gallinger@uhn.ca.
³¹ Department of Surgery, University of Toronto, Toronto, Ontario, Canada. steven.gallinger@uhn.ca.
³² Princess Margaret Cancer Centre, Toronto, Ontario, Canada. faiyaz.notta@gmail.com.
³³ PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. faiyaz.notta@gmail.com.
³⁴ Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. faiyaz.notta@gmail.com.

^# Contributed equally.

PMID: 32051610
DOI: 10.1038/s41588-020-0588-3

Published Erratum

Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution

Michelle Chan-Seng-Yue et al. Nat Genet. 2020 Apr.

. 2020 Apr;52(4):463.

doi: 10.1038/s41588-020-0588-3.

Authors

Affiliations

¹ Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
² PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
³ Genomics Technology Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
⁴ Wallace McCain Centre for Pancreatic Cancer, Department of Medical Oncology, Princess Margaret Centre University Health Network, University of Toronto, Toronto, Ontario, Canada.
⁵ Hepatobiliary/Pancreatic Surgical Oncology Program, University Health Network, Toronto, Ontario, Canada.
⁶ UHN Program in BioSpecimen Sciences, University Health Network, Toronto, Ontario, Canada.
⁷ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
⁸ Department of Pathology, University Health Network and University of Toronto, Toronto, Ontario, Canada.
⁹ Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
¹⁰ Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
¹¹ Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor, NY, USA.
¹² Department of Surgery, University of California San Diego, NCI-designated Comprehensive Cancer Center, La Jolla, CA, USA.
¹³ Department of Surgery and Cancer, Imperial College London, London, UK.
¹⁴ Pancreas Centre BC, Vancouver, British Columbia, Canada.
¹⁵ Department of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.
¹⁶ Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.
¹⁷ Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
¹⁸ Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
¹⁹ Bioinformatics, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
²⁰ Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
²¹ Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
²² The Goodman Cancer Research Centre of McGill University, Montreal, Quebec, Canada.
²³ Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
²⁴ Department of Computer Science, University of Toronto, Toronto, Ontario, Canada.
²⁵ Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.
²⁶ Department of Haematology, University of Cambridge, Cambridge, UK.
²⁷ Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
²⁸ PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. steven.gallinger@uhn.ca.
²⁹ Hepatobiliary/Pancreatic Surgical Oncology Program, University Health Network, Toronto, Ontario, Canada. steven.gallinger@uhn.ca.
³⁰ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. steven.gallinger@uhn.ca.
³¹ Department of Surgery, University of Toronto, Toronto, Ontario, Canada. steven.gallinger@uhn.ca.
³² Princess Margaret Cancer Centre, Toronto, Ontario, Canada. faiyaz.notta@gmail.com.
³³ PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. faiyaz.notta@gmail.com.
³⁴ Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. faiyaz.notta@gmail.com.

^# Contributed equally.

PMID: 32051610
DOI: 10.1038/s41588-020-0588-3

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

PubMed Disclaimer

Erratum for

Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.
Chan-Seng-Yue M, Kim JC, Wilson GW, Ng K, Figueroa EF, O'Kane GM, Connor AA, Denroche RE, Grant RC, McLeod J, Wilson JM, Jang GH, Zhang A, Dodd A, Liang SB, Borgida A, Chadwick D, Kalimuthu S, Lungu I, Bartlett JMS, Krzyzanowski PM, Sandhu V, Tiriac H, Froeling FEM, Karasinska JM, Topham JT, Renouf DJ, Schaeffer DF, Jones SJM, Marra MA, Laskin J, Chetty R, Stein LD, Zogopoulos G, Haibe-Kains B, Campbell PJ, Tuveson DA, Knox JJ, Fischer SE, Gallinger S, Notta F. Chan-Seng-Yue M, et al. Nat Genet. 2020 Feb;52(2):231-240. doi: 10.1038/s41588-019-0566-9. Epub 2020 Jan 13. Nat Genet. 2020. PMID: 31932696

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution

Affiliations

Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources